OK GO is the first commercially available software to support the implementation of a quantitative go/no-go decision-making framework in clinical trials.
A quantitative decision-making framework allows promising medicines to be accelerated, and ineffective ones to be terminated more quickly.
Defining your trial's decision-making criteria upfront ensures that go/no-go decisions can be made with little delay or bias.
Development of new medical products is time-consuming and expensive. Sponsors’ success relies on their ability to efficiently decide which development candidates to take forward, and which to terminate.
Sponsors need to make earlier decisions and develop more efficient processes to interpret incoming pre-clinical, clinical, or post-approval data.
Making correct go and no-go decisions with high confidence is essential to ensure that time and resources are optimally invested and effective products brought to market more quickly.